US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

ALPHA COGNITION INC

9.11

-0.1050-1.14%

Post-market: 9.110.00000.00%19:14 EDT

Volume:43.51K

Turnover:402.28K

Market Cap:145.86M

PE:-7.68

High:9.34

Open:9.16

Low:8.96

Close:9.21

Loading ...

Overview Company News Filings

Stonegate Capital Partners Updates Coverage on Alpha Cognition Inc. Following Successful Launch of ZUNVEYL

Alpha Cognition Price Target Maintained With a $20.00/Share by HC Wainwright & Co.

Alpha Cognition Q1 EPS $(0.13) Beats $(0.84) Estimate, Sales $2.93M Beat $954.50K Estimate

Alpha Cognition Inc. Reports Q1 2025 Results: Zunveyl Net Product Revenues at $347K, Net Loss Reduced to $2M

Alpha Cognition Inc. Reports First Quarter 2025 Financial Results and Operating Overview

THOMSON REUTERS

Alpha Cognition Inc - Company Expects Cash Runway of About Two Years

THOMSON REUTERS

Press Release: Alpha Cognition Inc. Reports First Quarter 2025 Financial Results and Operating Overview

Press Release: SERA PROGNOSTICS REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS

Press Release: Alpha Cognition to Report First Quarter 2025 Financial Results and Operating Overview

Alpha Cognition, Inc. Announces Participation in the D. Boral Capital Inaugural Global Conference

Alpha Cognition Strengthens Its Leadership Team With Appointment of Robert Wills to Board of Directors and Announces Departure of Existing Director John Havens

THOMSON REUTERS

Alpha Cognition Strengthens Its Leadership Team with Appointment of Robert Wills to Board of Directors and Announces Departure of Existing Director John Havens

Stonegate Capital Partners Updates Coverage on Alpha Cognition Inc. (ACOG) Q4 2024

Alpha Cognition FY 2024 GAAP EPS $(0.51) Misses $(0.08) Estimate

Alpha Cognition Inc: Qtrly Shr Loss $0.51

THOMSON REUTERS

Press Release: Alpha Cognition Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Operating Overview

Alpha Cognition Price Target Maintained With a $20.00/Share by HC Wainwright & Co.

Alpha Cognition to Report Fourth Quarter and Full Year 2024 Financial Results and Operating Overview

THOMSON REUTERS

Alpha Cognition to Report Fourth Quarter and Full Year 2024 Financial Results and Operating Overview

BUZZ-Alpha Cognition rises on commercial launch of Alzheimer's drug

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/ACOG/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ACOG","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ACOG\",,,,,undefined,":{"symbol":"ACOG","market":"US","secType":"STK","nameCN":"ALPHA COGNITION INC","latestPrice":9.105,"timestamp":1751054400000,"preClose":9.21,"halted":0,"volume":43509,"hourTrading":{"tag":"盘后","latestPrice":9.105,"preClose":9.105,"latestTime":"19:14 EDT","volume":16,"amount":143.955,"timestamp":1751066096830},"delay":0,"floatShares":9331035,"shares":16019787,"eps":-1.185811,"marketStatus":"Market Closed","change":-0.105,"latestTime":"06-27 16:00:00 EDT","open":9.16,"high":9.34,"low":8.96,"amount":402278.7503,"amplitude":0.04126,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.185811,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1751270400000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":9.21,"preHourTrading":{"tag":"盘前","latestPrice":9.3,"preClose":9.21,"latestTime":"08:32 EDT","volume":140,"amount":1302,"timestamp":1751027566708},"postHourTrading":{"tag":"盘后","latestPrice":9.105,"preClose":9.105,"latestTime":"19:14 EDT","volume":16,"amount":143.955,"timestamp":1751066096830},"volumeRatio":0.551890991678186},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ACOG\",,,,,undefined,":{"symbol":"ACOG","floatShares":9331035,"roa":"-26.72%","roe":"-56.79%","lyrEps":-2.019472,"volumeRatio":0.551890991678186,"shares":16019787,"dividePrice":0,"high":9.34,"amplitude":0.04126,"preClose":9.21,"low":8.96,"week52Low":3.75,"pbRate":"3.57","psRate":"49.80","week52High":11.4,"institutionHeld":0,"latestPrice":9.105,"eps":-1.185811,"divideRate":0,"volume":43509,"delay":0,"ttmEps":-1.185811,"open":9.16,"prevYearClose":5.89,"prevWeekClose":9.16,"prevMonthClose":9.33,"prevQuarterClose":5.06,"fiveDayClose":9.16,"twentyDayClose":10.09,"sixtyDayClose":4.85},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ACOG\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2536638140","title":"Stonegate Capital Partners Updates Coverage on Alpha Cognition Inc. Following Successful Launch of ZUNVEYL","url":"https://stock-news.laohu8.com/highlight/detail?id=2536638140","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536638140?lang=en_us&edition=fundamental","pubTime":"2025-05-19 22:26","pubTimestamp":1747664779,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alpha Cognition Inc. published the original content used to generate this news brief via Newsfile  on May 19, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250519:nNDL2R0CR5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ACOG"],"gpt_icon":0},{"id":"2535396675","title":"Alpha Cognition Price Target Maintained With a $20.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2535396675","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535396675?lang=en_us&edition=fundamental","pubTime":"2025-05-16 19:26","pubTimestamp":1747394760,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ACOG/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 16, 2025 07:26 ET (11:26 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACOG"],"gpt_icon":0},{"id":"2535803755","title":"Alpha Cognition Q1 EPS $(0.13) Beats $(0.84) Estimate, Sales $2.93M Beat $954.50K Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2535803755","media":"Benzinga","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535803755?lang=en_us&edition=fundamental","pubTime":"2025-05-16 04:58","pubTimestamp":1747342696,"startTime":"0","endTime":"0","summary":"Alpha Cognition (NASDAQ:ACOG) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of $(0.84) by 84.52 percent. This is a 85.06 percent increase over losses of $(0.87) per share from","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/05/45454800/alpha-cognition-q1-eps-0-13-beats-0-84-estimate-sales-2-93m-beat-954-50k-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACOG"],"gpt_icon":0},{"id":"2535084772","title":"Alpha Cognition Inc. Reports Q1 2025 Results: Zunveyl Net Product Revenues at $347K, Net Loss Reduced to $2M","url":"https://stock-news.laohu8.com/highlight/detail?id=2535084772","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535084772?lang=en_us&edition=fundamental","pubTime":"2025-05-15 20:30","pubTimestamp":1747312253,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alpha Cognition Inc. published the original content used to generate this news brief via Business Wire  on May 15, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250515:nNDL9ZlHp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACOG"],"gpt_icon":0},{"id":"2535847253","title":"Alpha Cognition Inc. Reports First Quarter 2025 Financial Results and Operating Overview","url":"https://stock-news.laohu8.com/highlight/detail?id=2535847253","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535847253?lang=en_us&edition=fundamental","pubTime":"2025-05-15 20:30","pubTimestamp":1747312201,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250515:nTUA1DV9M1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ACOG"],"gpt_icon":0},{"id":"2535477428","title":"Alpha Cognition Inc - Company Expects Cash Runway of About Two Years","url":"https://stock-news.laohu8.com/highlight/detail?id=2535477428","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535477428?lang=en_us&edition=fundamental","pubTime":"2025-05-15 20:30","pubTimestamp":1747312201,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250515:nTUA1DV9M1:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ACOG","BK4139"],"gpt_icon":0},{"id":"2535847193","title":"Press Release: Alpha Cognition Inc. Reports First Quarter 2025 Financial Results and Operating Overview","url":"https://stock-news.laohu8.com/highlight/detail?id=2535847193","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535847193?lang=en_us&edition=fundamental","pubTime":"2025-05-15 20:30","pubTimestamp":1747312200,"startTime":"0","endTime":"0","summary":"-- Launched ZUNVEYL  to US market on March 17, 2025. -- Secured business development licensing revenues of $2.6M for partnership. -- Cash and cash equivalents of $45.5 million as of March 31, 2025, compared. to $48.6 million as of December 31, 2024. At current cash utilization. rates, the Company expects a cash runway of approximately two years.Alpha Cognition Inc.   today announced its financial results for the first quarter ended March 31, 2025.\"We closed the quarter on a strong note, launching ZUNVEYL to the long-term care market,\" said Michael McFadden, Chief Executive Officer. \"We feel that the company is operating at a high level and are on schedule and within budget on all of our launch plans. Early market feedback on ZUNVEYL utilization reinforces our belief that ZUNVEYL can be a disruptive product for the Alzheimer's segment. The team is reporting successful patient stories that fuel our passion to tell more health care providers about ZUNVEYL.\". -- Alpha Cognition launched ZU","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACOG"],"gpt_icon":0},{"id":"2533966764","title":"Press Release: SERA PROGNOSTICS REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS","url":"https://stock-news.laohu8.com/highlight/detail?id=2533966764","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533966764?lang=en_us&edition=fundamental","pubTime":"2025-05-08 04:05","pubTimestamp":1746648300,"startTime":"0","endTime":"0","summary":"SALT LAKE CITY, May 7, 2025 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company , focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced financial results for the first quarter of 2025 ended March 31, 2025.-- Following release of full Prematurity Risk Assessment Combined With. results meeting primary success criteria, Sera is elevating engagement. -- Pursuing Medicaid opportunity, which represents approximately half of the. market opportunity for Sera's PreTRM Test; in discussions with several. Medicaid plans across three states for PreTRM test implementation pilots.Obstetricians and Gynecologists  2025 Annual Clinical & Scientific. interest in continued investigator-initiated evidence generation for the. First quarter 2025 revenue was $38,000 compared to nil for the same period of 2024.Net loss for the quarter was $8.2 million compared to $8.1","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4232","BK4139","R","BK4022","ACOG","BK4539","SERA"],"gpt_icon":0},{"id":"2532074253","title":"Press Release: Alpha Cognition to Report First Quarter 2025 Financial Results and Operating Overview","url":"https://stock-news.laohu8.com/highlight/detail?id=2532074253","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532074253?lang=en_us&edition=fundamental","pubTime":"2025-05-01 20:33","pubTimestamp":1746102780,"startTime":"0","endTime":"0","summary":"Conference Call Scheduled for May 15, 2025 4:30pm ET. Alpha Cognition Inc. , a biopharmaceutical company dedicated to advancing treatments for neurodegenerative diseases, today will announce financial results for the first quarter ended March 31, 2025 on May 15, 2025 after close of market.Following the release, management will host a conference call to review financial and operating results.To participate in the conference call, please use the dial-in information below:. Note, you can avoid long wait times for the operator by using the Call me feature and clicking the link below 15 minutes prior to the scheduled call start time:. This news release includes forward-looking statements within the meaning of applicable securities laws. Except for statements of historical fact, any information contained in this news release may be a forward--looking statement that reflects the Company's current views about future events and are subject to known and unknown risks, uncertainties, assumptions ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACOG"],"gpt_icon":0},{"id":"2531035751","title":"Alpha Cognition, Inc. Announces Participation in the D. Boral Capital Inaugural Global Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2531035751","media":"Newsfile","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531035751?lang=en_us&edition=fundamental","pubTime":"2025-04-30 19:30","pubTimestamp":1746012600,"startTime":"0","endTime":"0","summary":"Grapevine, Texas-- - Alpha Cognition, Inc. , today announced its participation in the D. Boral Capital Inaugural Global Conference, taking place May 14, 2025, at The Plaza Hotel in New York City.Michael McFadden, CEO, will be hosting one-on-one meetings on May 14th from 9:00 A.M. to 3:00 P.M. .To register for one-on-one meetings with management at The Plaza Hotel in New York City, interested parties should contact John Perez at jperez@dboralcapital.com.About Alpha Cognition, Inc.Alpha Cognition is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer’s disease for which there are limited or no treatment options. On July 26, 2024, the Company received approval by the FDA of the Company’s New Drug Application  for ZUNVEYL  previously known as ALPHA-1062 oral tablet formulation for the treatment of mild-to-moderate Alzheimer’s disease. The Company will now focus on the development of commercial manufacturin","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/alpha-cognition-inc-announces-participation-113000527.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/alpha-cognition-inc-announces-participation-113000527.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4144","BK4139","ET","BK4581","ACOG","BK4588","BK4561","BK4585","BK4590"],"gpt_icon":0},{"id":"2526669565","title":"Alpha Cognition Strengthens Its Leadership Team With Appointment of Robert Wills to Board of Directors and Announces Departure of Existing Director John Havens","url":"https://stock-news.laohu8.com/highlight/detail?id=2526669565","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526669565?lang=en_us&edition=fundamental","pubTime":"2025-04-10 20:30","pubTimestamp":1744288201,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250410:nTUA4NLMPJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ACOG","BK4139"],"gpt_icon":0},{"id":"2526266598","title":"Alpha Cognition Strengthens Its Leadership Team with Appointment of Robert Wills to Board of Directors and Announces Departure of Existing Director John Havens","url":"https://stock-news.laohu8.com/highlight/detail?id=2526266598","media":"Business Wire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526266598?lang=en_us&edition=fundamental","pubTime":"2025-04-10 20:30","pubTimestamp":1744288200,"startTime":"0","endTime":"0","summary":"VANCOUVER & DALLAS, April 10, 2025----Alpha Cognition Inc.  , a biopharmaceutical company committed to developing novel therapies for debilitating neurodegenerative disorders, today announced the appointment of Robert Wills, Ph.D., to its Board of Directors, effective immediately April 7, 2025. Dr. Wills brings decades of experience in the pharmaceutical and biotechnology industries, with a distinguished career in drug development, corporate strategy, and executive leadership.\"On behalf of the entire Board of Directors, it is a pleasure to welcome Rob, a highly accomplished industry veteran, to our team,\" said Michael McFadden, Chief Executive Officer of Alpha Cognition, Inc. \"His experience across a range of diverse strategic roles will be highly instrumental as we continue to advance our commercial launch of ZUNVEYL and advance our sublingual program for mild-to-moderate Alzheimer’s Disease. Our board looks forward to working with Robert and leveraging his unique expertise.\". ZUNVEYL","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/alpha-cognition-strengthens-leadership-team-123000065.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["TISI","BK4139","ACOG","BK4120"],"gpt_icon":0},{"id":"2524639121","title":"Stonegate Capital Partners Updates Coverage on Alpha Cognition Inc. (ACOG) Q4 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2524639121","media":"Newsfile","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524639121?lang=en_us&edition=fundamental","pubTime":"2025-04-02 04:27","pubTimestamp":1743539220,"startTime":"0","endTime":"0","summary":"Dallas, Texas-- - Alpha Cognition Inc. : Stonegate Capital Partners updates their coverage on Alpha Cognition Inc. . Alpha Cognition had a strong 2024 after raising $52.8M and uplisting to NASDAQ, significantly enhancing its capital base and market visibility. It completed commercial manufacturing for its lead product ZUNVEYL , secured a new U.S. patent extending exclusivity through 2044, and concluded phase one of a Department of Defense-funded study demonstrating the potential to treat head trauma from blasts.To view the full announcement, including downloadable images, bios, and more, click here.Successfully launched in U.S. LTC market; raised $52.8M, uplisted to Nasdaq , and secured patent protection through 2044.Signed $44M licensing deal for Asia; building international partnerships to diversify revenue and reduce risk.Strong start in $2B LTC market with experienced sales team; positive initial physician feedback driving awareness and adoption.Stonegate Capital Partners is a lead","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/stonegate-capital-partners-updates-coverage-202700071.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/stonegate-capital-partners-updates-coverage-202700071.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["MNQmain","TSYW.SI","TQQQ","BK4139","QID","ACOG",".IXIC","USAW.SI","USJW.SI","QLD","NVIW.SI","SQQQ","PSQ","NQmain"],"gpt_icon":1},{"id":"2523949655","title":"Alpha Cognition FY 2024 GAAP EPS $(0.51) Misses $(0.08) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2523949655","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523949655?lang=en_us&edition=fundamental","pubTime":"2025-03-31 20:38","pubTimestamp":1743424693,"startTime":"0","endTime":"0","summary":"Alpha Cognition (NASDAQ:ACOG) reported quarterly losses of $(0.51) per share which missed the analyst consensus estimate of $(0.08) by 537.5 percent.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/03/44560478/alpha-cognition-fy-2024-gaap-eps-0-51-misses-0-08-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACOG"],"gpt_icon":0},{"id":"2523949638","title":"Alpha Cognition Inc:  Qtrly Shr Loss $0.51","url":"https://stock-news.laohu8.com/highlight/detail?id=2523949638","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523949638?lang=en_us&edition=fundamental","pubTime":"2025-03-31 20:37","pubTimestamp":1743424635,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250331:nFWN3QE10R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ACOG"],"gpt_icon":0},{"id":"2523498379","title":"Press Release: Alpha Cognition Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Operating Overview","url":"https://stock-news.laohu8.com/highlight/detail?id=2523498379","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523498379?lang=en_us&edition=fundamental","pubTime":"2025-03-31 20:30","pubTimestamp":1743424200,"startTime":"0","endTime":"0","summary":"--  Raised $52.8 million in gross proceeds in Q4 2024 to support the. upcoming ZUNVEYL commercial launch and Nasdaq uplisting .-- Completed commercial manufacturing to support the ZUNVEYL launch.-- Successfully completed the first phase of a pre-clinical bomb-blast study. funded by a Department of Defense grant, demonstrating benzgalantamine's. efficacy and safety in treating head trauma from simulated bomb blasts.-- Cash and cash equivalents of $48.6 million as of December 31, 2024,compared to $3.7 million as of September 30, 2024 and $1.4 million as of. December 31, 2023. At current cash utilization rates, the Company expects. Alpha Cognition Inc.   today announced its financial results for the fourth quarter and full year ended December 31, 2024.\"We closed 2024 on a strong note, securing capital to support the ZUNVEYL commercial launch and assembling an experienced leadership team, \" said Michael McFadden, Chief Executive Officer. \"In early 2025, we completed the manufacturing of th","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACOG"],"gpt_icon":0},{"id":"2523106789","title":"Alpha Cognition Price Target Maintained With a $20.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2523106789","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523106789?lang=en_us&edition=fundamental","pubTime":"2025-03-31 19:19","pubTimestamp":1743419940,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ACOG/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 31, 2025 07:19 ET (11:19 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACOG"],"gpt_icon":0},{"id":"2520195617","title":"Alpha Cognition to Report Fourth Quarter and Full Year 2024 Financial Results and Operating Overview","url":"https://stock-news.laohu8.com/highlight/detail?id=2520195617","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520195617?lang=en_us&edition=fundamental","pubTime":"2025-03-20 04:30","pubTimestamp":1742416200,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250319:nTUA6NMNSL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ACOG"],"gpt_icon":0},{"id":"2520196534","title":"Alpha Cognition to Report Fourth Quarter and Full Year 2024 Financial Results and Operating Overview","url":"https://stock-news.laohu8.com/highlight/detail?id=2520196534","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520196534?lang=en_us&edition=fundamental","pubTime":"2025-03-20 04:30","pubTimestamp":1742416200,"startTime":"0","endTime":"0","summary":"Conference Call Scheduled for March 31, 2025 4:30pm ET. VANCOUVER, British Columbia & DALLAS, March 19, 2025----Alpha Cognition Inc. , a biopharmaceutical company dedicated to advancing treatments for neurodegenerative diseases, today announced that it will release financial results for the fourth quarter and full year ended December 31, 2024 on March 31, 2025 after close of market.Following the release, management will host a conference call to review financial and operating results.To participate in the conference call, please use the dial-in information below:. This news release includes forward-looking statements within the meaning of applicable securities laws. Except for statements of historical fact, any information contained in this news release may be a forwardlooking statement that reflects the Company’s current views about future events and are subject to known and unknown risks, uncertainties, assumptions and other factors that may cause the actual results, levels of activi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/alpha-cognition-report-fourth-quarter-203000431.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ACOG"],"gpt_icon":0},{"id":"2520670948","title":"BUZZ-Alpha Cognition rises on commercial launch of Alzheimer's drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2520670948","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520670948?lang=en_us&edition=fundamental","pubTime":"2025-03-18 21:45","pubTimestamp":1742305522,"startTime":"0","endTime":"0","summary":"BUZZ-Alpha Cognition rises on commercial launch of Alzheimer's drug** Drug developer Alpha Cognition ACOG.O rises 12.5% to $5.91** ACOG says it has launched its oral therapy, Zunveyl, commercially to treat mild to moderate Alzheimer's disease ** Alzheimer's is a progressive brain disorder that slowly destroys memory, thinking skills, and eventually the ability to do simple tasks, which is the most common form of dementia affecting nearly 7 million people** Co says patients can now access the drug in 5 milligram , 10 mg and 15 mg doses** Zunveyl was approved by the FDA to treat AD in July 2024** Brokerage H.C. Wainwright estimates Zunveyl to generate $540 millon in peak annual sales in the US by the late 2030s** As of last close, ACOG down ~65% in the past 12 months  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250318:nL4N3Q10YV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACOG","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":49,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ACOG\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-15","symbol":"ACOG","fiscalQuarterEnding":"2025/03","expectedEps":-0.58,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747281600000,"reportTimeType":"post","actualEps":-0.2},{"market":"US","date":"2025-03-31","symbol":"ACOG","fiscalQuarterEnding":"2024/12","expectedEps":-0.48,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1743393600000,"reportTimeType":"post","actualEps":-0.51}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ACOG\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ACOG\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1742356800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ACOG\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ACOG","date":"2025-06-27","current":-12.674691,"percent":0.098039,"low":-14.553188,"twenty":-8.112302,"median":-6.314587,"eighty":-5.6646,"high":-2.141254,"avg":-7.325323,"sd":2.737702,"marketCap":147542238},"quantilePoints":[{"date":"2024-11-15","current":-5.518409,"twenty":-5.518409,"median":-5.518409,"eighty":-3.492116,"marketCap":89218230.86},{"date":"2024-11-22","current":-6.095906,"twenty":-6.0779,"median":-6.040783,"eighty":-5.518409,"marketCap":89580038.69},{"date":"2024-11-29","current":-7.052964,"twenty":-6.126453,"median":-6.040783,"eighty":-5.612398,"marketCap":103759893.65},{"date":"2024-12-06","current":-6.313396,"twenty":-6.313396,"median":-6.095906,"eighty":-5.994414,"marketCap":92879715.89},{"date":"2024-12-13","current":-5.804676,"twenty":-6.309556,"median":-6.047523,"eighty":-5.928174,"marketCap":85395665.51},{"date":"2024-12-20","current":-3.792145,"twenty":-6.289737,"median":-6.03741,"eighty":-5.564347,"marketCap":55788252.01},{"date":"2024-12-27","current":-5.520861,"twenty":-6.27191,"median":-5.988356,"eighty":-5.512882,"marketCap":81220325},{"date":"2025-01-03","current":-6.174218,"twenty":-6.276367,"median":-6.018645,"eighty":-5.517304,"marketCap":90832197},{"date":"2025-01-10","current":-6.228664,"twenty":-6.280824,"median":-6.044156,"eighty":-5.518409,"marketCap":91633187},{"date":"2025-01-17","current":-6.479118,"twenty":-6.381986,"median":-6.114998,"eighty":-5.51988,"marketCap":95317738},{"date":"2025-01-24","current":-6.827574,"twenty":-6.433383,"median":-6.156206,"eighty":-5.546995,"marketCap":100444070},{"date":"2025-01-31","current":-6.533564,"twenty":-6.529208,"median":-6.174218,"eighty":-5.650957,"marketCap":96118728},{"date":"2025-02-07","current":-6.424671,"twenty":-6.533564,"median":-6.22812,"eighty":-5.770729,"marketCap":94516749},{"date":"2025-02-14","current":-6.228664,"twenty":-6.533564,"median":-6.228664,"eighty":-5.853338,"marketCap":91633187},{"date":"2025-02-21","current":-6.860242,"twenty":-6.561876,"median":-6.283111,"eighty":-5.928174,"marketCap":100924664},{"date":"2025-02-28","current":-6.533564,"twenty":-6.583654,"median":-6.313396,"eighty":-5.93555,"marketCap":96118728},{"date":"2025-03-07","current":-5.83665,"twenty":-6.561876,"median":-6.313396,"eighty":-5.93555,"marketCap":85866063},{"date":"2025-03-14","current":-6.130661,"twenty":-6.544453,"median":-6.27751,"eighty":-5.928174,"marketCap":90191406},{"date":"2025-03-21","current":-6.043547,"twenty":-6.542275,"median":-6.261332,"eighty":-5.928174,"marketCap":88909823},{"date":"2025-03-28","current":-5.782204,"twenty":-6.533564,"median":-6.228664,"eighty":-5.862785,"marketCap":85065074},{"date":"2025-04-04","current":-5.461466,"twenty":-6.533564,"median":-6.206886,"eighty":-5.804122,"marketCap":79938742},{"date":"2025-04-11","current":-4.56399,"twenty":-6.533564,"median":-6.185107,"eighty":-5.723114,"marketCap":66802511},{"date":"2025-04-17","current":-4.651549,"twenty":-6.533564,"median":-6.172541,"eighty":-5.520861,"marketCap":68084094},{"date":"2025-04-25","current":-5.538079,"twenty":-6.522675,"median":-6.13409,"eighty":-5.512882,"marketCap":81060122},{"date":"2025-05-02","current":-6.545003,"twenty":-6.522675,"median":-6.114327,"eighty":-5.512882,"marketCap":95798326},{"date":"2025-05-09","current":-8.099168,"twenty":-6.533564,"median":-6.14155,"eighty":-5.51619,"marketCap":118546423},{"date":"2025-05-16","current":-7.453423,"twenty":-6.566232,"median":-6.174218,"eighty":-5.518409,"marketCap":109094749},{"date":"2025-05-23","current":-11.959073,"twenty":-6.642457,"median":-6.203155,"eighty":-5.518409,"marketCap":139211949},{"date":"2025-05-30","current":-13.885736,"twenty":-6.84282,"median":-6.227575,"eighty":-5.520371,"marketCap":161639650},{"date":"2025-06-06","current":-13.307738,"twenty":-6.982767,"median":-6.228664,"eighty":-5.534635,"marketCap":154911340},{"date":"2025-06-13","current":-13.218285,"twenty":-7.145541,"median":-6.27191,"eighty":-5.555592,"marketCap":153870054},{"date":"2025-06-20","current":-12.296239,"twenty":-7.475313,"median":-6.294194,"eighty":-5.575706,"marketCap":143136796},{"date":"2025-06-27","current":-12.674691,"twenty":-8.112302,"median":-6.314587,"eighty":-5.6646,"marketCap":147542238}],"updateTime":1751131855274}}}